| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Orthofix Medical Inc. | Director | Common Stock | 83,706 | $1,030,420 | $12.31 | 18 Jun 2025 | Direct |
| Anika Therapeutics, Inc. | Director | Common Stock | 49,871 | $732,604 | $14.69 | 20 Jun 2025 | Direct |
| Aprea Therapeutics, Inc. | Director | Common Stock | 10,229 | $16,570 | $1.62 | 05 Jun 2025 | Direct |
| R1 RCM Inc. /DE | Director | Common Stock | 0 | $0 | $14.30 | 19 Nov 2024 | Direct |
| Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4,185 | 20 Jun 2024 | Direct | ||
| Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4,185 | 05 Jun 2025 | Direct | ||
| R1 RCM Holdco Inc. | Director | Common Stock | 0 | $25.78 | 21 Jun 2022 | Direct | |
| R1 RCM Holdco Inc. | Director | Director Stock Option (right to buy) | 0 | 21 Jun 2022 | Direct | ||
| R1 RCM Holdco Inc. | Director | Restricted Stock Units | 0 | $26.69 | 21 Jun 2022 | Direct | |
| R1 RCM Inc. /DE | Director | Director Stock Option (right to buy) | 0 | 19 Nov 2024 | Direct | ||
| SeaSpine Holdings Corp | Director | Common Stock | 0 | $8.35 | 05 Jan 2023 | Direct | |
| SeaSpine Holdings Corp | Director | Stock Option (right to buy) | 0 | 05 Jan 2023 | Direct |